Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Skin Cancer and ESMO 2022

The Skin Cancer Channel on VJOncology is supported by Replimune. Supporters have no influence over the production of the content.

View overview page
0:35
Potential advantages of neoadjuvant immunotherapy for melanoma
Sapna Patel • 12 Sep 2022
0:27
SWOG S1801: Escalation vs. deescalation of immunotherapy for melanoma
Sapna Patel • 12 Sep 2022
1:40
SWOG S1801: Benefits of neoadjuvant immunotherapy for patients with resectable melanoma
Sapna Patel • 12 Sep 2022
1:28
Highlights from ESMO 2022 in melanoma
Omid Hamid • 12 Sep 2022
2:43
Phase I dose escalation of IMC-F106C, a PRAME × CD3 ImmTAC bispecific protein in solid tumors
Omid Hamid • 12 Sep 2022
6:43
Late hematological malignancies of systemic anticancer therapies
Jean Baptiste Micol • 12 Sep 2022
0:31
The inclusion of patients with brain metastases in clinical trials
Angelika Starzer • 10 Sep 2022
1:39
OpACIN and OpACIN-neo: Neoadjuvant immunotherapy for advanced melanoma
Judith Versluis • 10 Sep 2022
3:09
ESMO 2022: Highlights from the Presidential Symposium
Solange Peters • 11 Sep 2022
1:15
The potential applications of ctDNA in melanoma
Matteo Carlino • 11 Oct 2022
1:31
Overcoming resistance to MAPK inhibition in melanoma
Matteo Carlino • 11 Oct 2022
3:23
CD8 T-cell receptor signatures of response to checkpoint immunotherapy
Benjamin Fairfax • 10 Sep 2022
0:37
TILs prolong PFS compared with pembrolizumab in advanced melanoma
Sebastian Kobold • 27 Sep 2022
2:38
EVICITON: ICT01 plus pembro induces broad antitumor response in NSCLC, bladder cancer and melanoma
Sebastian Kobold • 27 Sep 2022
3:35
Enhancing immunotherapy with cytokines
Sebastian Kobold • 27 Sep 2022
2:38
Updates in melanoma at ESMO 2022
Paolo Ascierto • 12 Sep 2022
The Skin Cancer Channel on VJOncology is supported by Replimune. Supporters have no influence over the production of the content.
If you are interested in becoming a supporter of The Skin Cancer Channel, please contact us .
The content of VJOncology is intended for healthcare professionals